Sankar Navaneethan, MD
Enriched profileGarabed Eknoyan MD Endowed Professor of Medicine; Associate Chief, Section of Nephrology; Director of Clinical Research, Section of Nephrology; Chief, Renal Section, Michael E. DeBakey VA Medical Center · Baylor College of Medicine
Sankar Navaneethan is Garabed Eknoyan MD Endowed Professor of Medicine; Associate Chief, Section of Nephrology; Director of Clinical Research, Section of Nephrology; Chief, Renal Section, Michael E. DeBakey VA Medical Center at Baylor College of Medicine. OpenAlex indexes 452 publications with 44,855 citations (h-index 80); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Sankar Dass Navaneethan, MD, is Garabed Eknoyan MD Endowed Professor of Medicine at Baylor College of Medicine, Houston, TX. The public record shows 452 publications with 44,855 citations (h-index 80), centered on Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, Diabetes Treatment and Management. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 16 companies, 1 NIH-funded awards (2014–2015).
- Most recent indexed publication: 2026 · The Journal of clinical endocrinology and metabolism
- Top research focus: Chronic Kidney Disease and Diabetes
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 16 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 7 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 224.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- CRIC-Visceral Adiposity and Physical Fitness in Chronic Kidney Disease
Sponsor: Baylor College of Medicine
- Effects of Intentional Weight Loss Interventions in Chronic Kidney Disease
Sponsor: The Cleveland Clinic
Industry payments
Updated 27 Aug 2026
16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Alnylam Pharmaceuticals Inc.Program year20258 payments$34,165openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202516 payments$12,130openpaymentsdata.cms.gov ↗
- Novartis Pharmaceuticals CorporationProgram year20256 payments
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2014–2015 per NIH RePORTER. The latest:
- MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE
Baylor College of Medicine
FY2026$117,167K24HL161414 - MENTORED PATIENT-ORIENTED RESEARCH TOWARDS OPTIMIZING CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE
Baylor College of Medicine
FY2025$117,491K24HL161414 - Optimizing Renin Angiotensin System Blocker Use among Veterans with Kidney Disease
Michael E Debakey Va Medical Center
FY2025I01HX002917
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes.
The Journal of clinical endocrinology and metabolism
Article2026 - Safety and Synergy of Finerenone and Empagliflozin in Lowering Blood Pressure.
Hypertension (Dallas, Tex.
Article2026 - Cardiovascular Outcomes and Acute Kidney Injury Risk with Combination Therapies in Type 2 Diabetes and Chronic Kidney Disease.
Nephrology, dialysis, transplantation
Article2026 - Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease.
Clinical journal of the American Society of Nephrology
Article2026 - Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease.
International journal of nephrology and renovascular disease
Review2026
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03Heart Disease and Stroke Statistics—2021 Update5,782 citations2021
- 04
- 05
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/sankar-navaneethan-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/sankar-dass-navaneethan-039589249
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by others
where others cite or feature them- Other
kidney.org/press-room/houston-s-sankar-dass-navaneethan-md-ms-mph-named-nkf-s-garabed-eknoyan-award-winner
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗ - ResearchGate
researchgate.net/scientific-contributions/Sankar-D-Navaneethan-50097170
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗ - Doximity
Doximity profile listing: Nephrology, Houston, TX
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →bcm.edu ↗
- Associate Editor
American Journal of Kidney Diseases
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org ↗
Secondary affiliations
appointments beyond the home institution- Chief
Renal Section, Michael E. DeBakey VA Medical Center, Houston, TX
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →houston.hsrd.research.va.gov ↗ - Co-lead
Resources Module, Consortium for Translational and Precision Health, Baylor College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →prnewswire.com ↗
Media & interviews
press, podcasts and appearances- ASN Podcast / nephSAP Guest Editor Interview: "ESKD: A Therapeutic Triumph of Nephrology" with Alice Sheridan
MD and Martina McGrath, MD (nephSAP Vol. 24, No. 4)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
William Mitch, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine